Home > Boards > US OTC > Biotechs >

Sangamo Biosciences Inc. (SGMO)

SGMO RSS Feed
Add SGMO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/16/2020 10:15:45 AM - Followers: 74 - Board type: Free - Posts Today: 0

SANGAMO’S MISSION

We are committed to translating ground-breaking science into genomic medicines that transform patients' lives.

PIONEERING GENETIC CURES

Sangamo Therapeutics is a genomic medicine company conducting research & development across four distinct but complementary technology platforms – gene therapy, cell therapy, in vivo genome editing, and in vivo genome regulation. The optionality and diversity inherent to Sangamo’s technology platform enables us to design therapeutic approaches to resolve the underlying genetic causes of disease, using whichever technology is best suited to deliver that treatment.

Because Sangamo’s technology platforms are related, we are applying learnings across studies to optimize each individual platform and uncover research and development paths forward. Sangamo is best known for developing our proprietary gene editing technology, zinc finger nucleases (ZFNs). Our technology team continues to optimize ZFNs for the three key dimensions of genome editing: precision, efficiency, and specificity.

Ex vivo gene-edited cell therapy is the most straightforward application of ZFN technology. It builds on early experience with HIV clinical studies and is applied to hematological disorders and oncology. Our cell therapy portfolio also includes ex vivo engineered regulatory T-cells (CAR-Tregs) for application in autoimmunity and inflammation.

The insights gained about molecular biology, cassette engineering, and delivery through in vivo application of ZFNs led to our gene therapy program using AAV, which is advancing in the clinic. Zinc finger protein engineering and AAV delivery are also foundational for our zinc finger protein-transcription factor (ZFP-TF) genome regulation technology, which we are applying in CNS diseases.

With our robust history of genomic medicine firsts, unmatched technology platform, and growing manufacturing and clinical development capabilities, Sangamo believes we are the company to realize the vision of genomic medicine.

 
 
SGMO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SGMO News: Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences 11/05/2020 08:00:00 AM
SGMO News: Quarterly Report (10-q) 11/04/2020 04:25:20 PM
SGMO News: Current Report Filing (8-k) 11/04/2020 04:07:51 PM
SGMO News: Sangamo Therapeutics Reports Business Highlights and Third Quarter 2020 Financial Results 11/04/2020 04:01:00 PM
SGMO News: Sangamo Therapeutics Announces Third Quarter 2020 Conference Call and Webcast 10/28/2020 04:15:00 PM
PostSubject
#373   I agree! I have options that are going DTGoody 07/16/20 10:15:45 AM
#372   Took at starter almost a billion in cash Fress 07/16/20 04:25:42 AM
#371   Come on SGMO Move up to around $13 DTGoody 07/01/20 07:48:18 PM
#370   I wonder why SGMO has gone down so DTGoody 06/19/20 04:47:04 PM
#369   Updated the Ibox MWM 06/11/20 03:15:32 PM
#368   https://pbs.twimg.com/media/EaQJT1cWoAAXAHR?format=jpg&name=large MWM 06/11/20 03:01:33 PM
#367   $SGMO Call Volume pic MWM 06/11/20 02:35:39 PM
#366   PFE is a partner with SGMO in Hemo. MWM 06/11/20 02:33:44 PM
#365   $SGMO chart looks great! MWM 06/11/20 02:31:20 PM
#364   $PFE ceo has stated that they will be MWM 06/11/20 12:58:10 PM
#363   Something seems to be brewing at SGMO. Recent hitekmastr 05/21/20 07:44:15 AM
#362   Pump pump pump Cramer Porterhouse10 03/05/20 06:42:49 PM
#361   Just on Cramer Leezee Life Strategies 03/05/20 06:38:18 PM
#360   $SGMO Today"s volume , 5.5 mil, is the Fress 03/03/20 05:28:25 AM
#359   The Deal With Biogen Boosts The Recommendation To Fress 03/02/20 07:44:37 PM
#358   Gilead, Sangamo strike $3B off-the-shelf CAR-T deal Fress 03/02/20 04:14:09 PM
#357   We will see a bidding war for this Fress 03/02/20 03:52:32 PM
#356   More clinical updates and Analysts upgrades coming Biogen Fress 03/02/20 03:32:40 PM
#355   SGMO - BIIB Global Neuro Deal Validates ZNF Fress 03/02/20 10:15:55 AM
#354   SGMO - BIIB Global Neuro Deal Validates ZNF Fress 03/02/20 10:15:49 AM
#353   https://investor.sangamo.com/news-releases/news-release-details/biogen-and-sanga Fress 03/02/20 08:19:20 AM
#352   SGMO has major potential just signed huge deal Fress 03/02/20 08:16:09 AM
#351   * * $SGMO Video Chart 02-28-2020 * * ClayTrader 02/28/20 05:42:31 PM
#350   More like earth shattering. In a better environment The Canes 02/27/20 07:36:30 PM
#349   https://finance.yahoo.com/news/biogen-sangamo-announce-global-collaboration-2106 steadykickin 02/27/20 05:01:11 PM
#348   Nice news yankees18 02/27/20 04:07:10 PM
#347   IMO they'd (PFE) be getting a steal at ByMorStock 12/12/19 06:18:02 PM
#346   SGMO Some coments in stocktwits about PFIZER BUYOUT CHARLIE125 12/12/19 03:20:27 PM
#345   Unfortunately The CEO and the IR/PR dude need to ByMorStock 12/10/19 03:43:53 PM
#344   well, that was a big fizzle. jbaxter 12/10/19 03:16:57 PM
#343   Awesome background on ASH and SGMO here ByMorStock 12/08/19 06:15:22 PM
#342   "Top Notch Program, Platform and Leadership ByMorStock 12/08/19 04:00:46 PM
#341   SGMO and PFE HUGE News on Drug Trial ByMorStock 12/07/19 01:54:33 PM
#340   TA of SGMO https://msmoneymoves.com/2019/07/08/sangamo-therapeutics-inc-nasdaq-s Zmill 07/13/19 09:05:47 AM
#339   Good stuff, thanks roadkilll 07/10/19 09:35:06 PM
#338   Are you reading the other SGMO site I ciciagt 07/09/19 01:56:19 PM
#337   Market really doesn't like Sangamo's PR history roadkilll 07/09/19 11:11:18 AM
#336   Biomarin needs to go commercial as soon as possible roadkilll 07/08/19 09:42:18 PM
#335   Sangamo has begun the tech transfer for the roadkilll 07/08/19 09:29:09 PM
#334   “Jefferies: SGMO providing reasons for pts+docs to hesitate ciciagt 07/08/19 07:23:27 PM
#333   “WF - SGMO: Hem A Update, Emerging Best-In-Class ciciagt 07/08/19 07:21:11 PM
#332   “BREAKING NEWS - Sangamo (SGMO) - SB-525 Looks ciciagt 07/08/19 07:19:45 PM
#329   * * $SGMO Video Chart 07-08-2019 * * ClayTrader 07/08/19 04:10:56 PM
#328   $11.50, raised $145 million roadkilll 07/08/19 04:02:01 PM
#326   RICHMOND, Calif., April 3, 2019 /PRNewswire/ -- Sangamo ciciagt 04/03/19 11:17:14 PM
#325   * * $SGMO Video Chart 04-02-2019 * * ClayTrader 04/02/19 05:23:27 PM
#324   Sangamo price target raised to $34 from $24 ciciagt 04/02/19 10:50:50 AM
#323   ciciagt... Thanks for posting... jessellivermore 04/02/19 09:46:37 AM
#322   “After getting slammed two months ago after rolling ciciagt 04/02/19 09:38:40 AM
#321   Nice update. I have been intrigued by what steadykickin 03/07/19 11:59:39 AM
PostSubject
Consent Preferences